|
Re: must read article --should her2+ breast cancer be divided into ER+ vs ER- subtype
Thanks Lani
I guess it's the not knowing that makes oncologists cautious about predicting how individual breast cancers will behave. Set aside with individual immune responses the puzzle is very complex indeed!
Ellie
|